UTI HEALTHCARE FUND

Sectoral – Healthcare | (Erstwhile UTI Pharma & Healthcare Fund)
An open ended equity scheme investing in the Healthcare Services Sector. | Data as on 30 November 2021

Investment Objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equities and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Inception Date
28th June, 1999
Fund Manager
Mr. V Srivatsa - B.Com., ACA, CWA, PGDM (IIM-I)
Managing the scheme since Mar-2017
Fund AUM
Fund size monthly average : 827.25 Crore
Closing AUM : 823.16 Crore
High/Low NAV in the month
High Growth Option : 166.3391
Low Growth Option : 158.6733
Total expense ratio (%)
Regular : 2.48
Direct : 1.25
Minimum Investment Amount
Growth, IDCW: 5,000/-
Plans/Options (Regular / Direct)
Growth option IDCW option with Payout and Reinvestment
No. of Unit Holding Accounts 51,885
Market Capitalisation (%)
Large
Mid
Small
Fund
56
20
24
Benchmark
62
25
13
Load Structure
Entry Load : Nil
Exit Load : < 30 days – 1%;≥ 30 days – Nil
NAV per unit as on 30th November, 2021
Regular Growth Option 163.4730
Regular IDCW Option 126.3419
Direct Growth Option 177.4922
Direct IDCW Option 137.1897
Benchmark Index
S&P BSE Healthcare
SIP/SWP/STRIP
Digital Factsheet - Checkbox Image
Fund Size 827.25 Crore (Monthly Average as on 30/11/2021)
Overweight (Top 5)
% of Nav
Underweight (Top 5)
% of Nav
Aurobindo Pharma Ltd.
3.69
Apollo Hospitals Enterprise Ltd.
-4.59
Eris Lifesciences Ltd
3.40
Sun Pharmaceuticals Industries Ltd.
-4.43
Ajanta Pharma Ltd
3.26
Divis Laboratories Ltd.
-3.91
Fortis Healthcare Ltd.
3.02
Laurus Labs Ltd.
-3.03
Krishna Institute Of Medical Science Ltd
2.89
Max Healthcare Institute Ltd
-2.13
UTI Healthcare Fund (Formerly known as UTI Pharma & Healthcare Fund) IDCW Declared
Year
IDCW 
Per unt
NAV (Cum Div )
Face Value (per unit)
NAV Date
Record Date
2006
25%
2.50
21.34
10.00
10-01-2006
17-01-2006
2008
15%
1.50
20.91
10.00
26-08-2008
02-09-2008
2010
17%
1.70
32.65
10.00
28-10-2010
04-11-2010

The scheme IDCW details under regular plan.
Disclaimer:Pursuant to payment of Dividend/Bonus, the Nav of the income distribution cum capital withdrawal options of the schemes would fall to the extent of payout and statutory levy (if applicable)

Equity
% of NAV
Dr Reddy's Laboratories Ltd.
9.49
Cipla Ltd.
8.94
Sun Pharmaceuticals Industries Ltd.
7.97
Aurobindo Pharma Ltd.
6.52
Divis Laboratories Ltd.
5.57
Fortis Healthcare Ltd.
5.25
Lupin Ltd.
4.46
Apollo Hospitals Enterprise Ltd.
4.14
Ajanta Pharma Ltd.
4.05
Eris Lifesciences Ltd
3.71
Krishna Institute Of Medical Science Ltd
3.16
IPCA Laboratories Ltd.
2.83
FDC Ltd.
2.82
Alembic Pharmaceuticals Ltd.
2.76
Narayana Hrudayalaya Ltd
2.68
J.B.Chemicals & Pharmaceuticals Ltd
2.63
Cadila Healthcare Ltd.
2.26
Biocon Ltd.
2.03
Alkem Laboratories Ltd
1.98
Metropolis Healthcare Ltd
1.81
Poly Medicure Ltd.
1.81
Advanced Enzyme Technologies Ltd
1.78
Torrent Pharmaceuticals Ltd.
1.62
Suven Pharmaceuticals Ltd
1.31
Abbott India Ltd.
1.30
Gland Pharma Ltd
1.29
AMI Organics Ltd
1.29
Proctor & Gamble Health Ltd
1.26
Windlas Biotec Ltd
0.83
Net Current Assets
2.45
TOTAL
100.00
% of top 10 stocks 
60.09
Median Market Cap ( Cr) 
40,353
Weighted Average Market Cap 
55,282
Number of Securities 
29
All figures given are provisional and unaudited.
Quantitative Indicators
Fund
Benchmark
Beta
0.89
1
Standard Deviation (Annual)
18.02%
19.76%
Sharpe ratio
1.15%
Portfolio Turnover Ratio (Annual)
0.47
P/B
6.45
8.04
P/E
38.18
43.56
RoE
15.92
15.63
     
Fund Performance Vs Benchmark (CAGR) as on 30th November, 2021 Growth of 10000
Period
NAV Growth (%)
S&P BSE
Healthcare (%)
Nifty 50 (%)
NAV Growth 
()
S&P BSE
Healthcare
()
Nifty 50 ()
1 Year
22.46
26.20
32.49
12,246
12,620
13,249
3 Years
24.18
21.98
17.38
19,161
18,159
16,180
5 Years
12.35
10.85
17.04
17,906
16,742
21,971
Since inception*
14.68
14.96
NA
216,256
228,421
NA

Different plans have a different expense structure. The performance details provided herein are of regular plan.
*Compounded annualized Growth Rate.
For performance details of other Schemes managed by the Fund Manager, please refer the respective Scheme sheets as listed Please click here in ‘Fund Manager Summary’. N.A Not Available. Schemes Managed by Mr. V Srivatsa.
As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of Nifty Pharma. PRI values from 28th June 1999 to 3rd April 2006. TRI Value From 4th April 2006.
The performance of the benchmark is calculated using total return index variant of the benchmark index.

Period
Investment Amount ()
Value- Fund ()
S&P BSE
Healthcare
()
Nifty 50 ()
Yield (%) Fund
Yield (%)
S&P BSE
Healthcare
Yield (%)
Nifty 50
1 Year
120,000
128,677
130,857
133,973
13.69
17.21
22.30
3 Years
360,000
565,022
562,737
513,194
31.60
31.29
24.45
5 Years
600,000
1,020,503
1,000,113
944,147
21.39
20.55
18.19
7 Years
840,000
1,443,847
1,391,100
1,478,007
15.20
14.16
15.86
10 Years
1,200,000
2,611,659
2,533,681
2,624,023
14.87
14.30
14.95
15 Years
1,800,000
6,406,892
6,474,669
5,236,941
15.44
15.56
13.11
Since inception*
2,040,000
8,495,172
8,721,863
7,160,468
15.07
15.33
13.37

Note: Systematic Investment Plan (SIP) returns are worked out assuming investment of 10,000/- every month at NAV per unit of the scheme as on the first working day for the respective time periods. The loads have not been taken into account.*Since inception for above mentioned schemes is taken for the period December 2004 to November 2021 (Since SIP facility was introduced in November 2004. Past performance may or may not be sustained in future.

*Investors should consult their Mutual Fund Distributor if in doubt about whether the product is suitable for them.

  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities in the Healthcare Service sector

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Riskometer